BHP, Rio Tinto shares rise as peer Vale posts smaller-than-feared Q2 profit drop
Investing.com - Sorrento Therape reported on Friday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Sorrento Therape announced earnings per share of $-0.200 on revenue of $17.40M. Analysts polled by Investing.com EPS of $-0.280 on revenue of $19.13M.
Sorrento Therape 's are down 61% and is trading at $1.812 , still down 72.59% from its 52 week high of $6.61 set on Friday, November 12, 2021.
Sorrento Therape shares gained 11.82% to trade at $1.812 in intra-day trade the report.
Sorrento Therape follows other major Healthcare sector earnings this month
Sorrento Therape's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar